Showing results (141-150 of 401) with videos related to
Sort By:
Pageof 41
Psychosomatic Medicine|August 12, 2024
Mediators of a Mindfulness-Based Intervention for Younger Breast Cancer Survivors: Effects on Depressive SymptomsJ Richard T Korecki, Patricia A Ganz, Ann H Partridge, et al.JCO Oncology Practice|June 25, 2024
Moderators of Intervention Efficacy in the Pathways to Wellness Trial of Survivorship Education and Mindfulness Meditation for Younger Breast Cancer SurvivorsJ Richard Tyrus Korecki, Patricia A Ganz, Ann H Partridge, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2011
Breast cancer survivors' perceptions of survivorship care optionsErica L Mayer, Adrienne B Gropper, Bridget A Neville, et al.American Journal of Cancer Research|January 11, 2023
Selection of endpoints in breast cancer clinical trials: a qualitative study of key trial stakeholdersWanyuan Cui, Kelly-Anne Phillips, Richard A Anderson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 12, 2013
Effect of age on breast cancer outcomes in women with human epidermal growth factor receptor 2-positive breast cancer: results from a herceptin adjuvant trialAnn H Partridge, Shari Gelber, Martine J Piccart-Gebhart, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2014
Developing a service model that integrates palliative care throughout cancer care: the time is nowAnn H Partridge, Davinia S E Seah, Tari King, et al.Breast Cancer Research and Treatment|September 14, 2022
Early postoperative psychological distress as a mediator of subsequent persistent postsurgical pain outcomes among younger breast cancer patientsJenna M Wilson, Carin A Colebaugh, K Mikayla Flowers, et al.Clinical Breast Cancer|March 27, 2012
Quality of life in long-term survivors of metastatic breast cancerJane L Meisel, Susan M Domchek, Robert H Vonderheide, et al.The Oncologist|April 10, 2013
Long-term risk perceptions of women with ductal carcinoma in situKathryn J Ruddy, Meghan E Meyer, Anita Giobbie-Hurder, et al.Clinical Breast Cancer|June 28, 2014
Extended therapy with letrozole and ovarian suppression in premenopausal patients with breast cancer after tamoxifenKathryn J Ruddy, Stephen D DeSantis, William Barry, et al.Pageof 41